[go: up one dir, main page]

AR043205A1 - Derivados de benceno sustituidos con trimeros macrociclicos - Google Patents

Derivados de benceno sustituidos con trimeros macrociclicos

Info

Publication number
AR043205A1
AR043205A1 ARP040100490A ARP040100490A AR043205A1 AR 043205 A1 AR043205 A1 AR 043205A1 AR P040100490 A ARP040100490 A AR P040100490A AR P040100490 A ARP040100490 A AR P040100490A AR 043205 A1 AR043205 A1 AR 043205A1
Authority
AR
Argentina
Prior art keywords
chz1
chz2
atom
meaning
trimeros
Prior art date
Application number
ARP040100490A
Other languages
English (en)
Inventor
Schirmer Heiko Dr
Hilmar Weinmann
Platzek Johannes Dr
Martin Jose Luis Dr
Juan R Harto
Riefke Bjom Dr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR043205A1 publication Critical patent/AR043205A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Complejos metálicos apropiados como sustancias de contraste de la fórmula general (1). A1 representa los radicales: -CONR1-(CH2)n-NR2-(CO-CHZ1-NH)m-CO-CHZ2-K, -CONR1-(CH2)p-(CONR2CH2)m-CHOH-CH2-K, -CH2-O-CH2)p-CHOH-CH2-K, -CH2-O-(CH2)n-NR1-(CO-CHZ1-NH)m-CO-CHZ2-K, -CH2-NR1-CO-(CHZ1-NH-CO)m-CHZ2-K, A2 tiene el mismo significado que A1 o en el caso que A1 tenga el significado mencionado en primer término también puede ser el radical -NR1-CO-(NR1)m-(CH2)p-NR2-(CO-CHZ1-NH)m-CO-CHZ2-K, donde R1 y R2 son independientemente un átomo de H, un grupo alquilo C1-2 o un grupo alquilo C1-12 monohidroxi, Z1 y Z2 son independientemente entre sí un átomo de H o un grupo metilo, n es el número 2-4, m es el número 0 o 1 y p es el número 1-4, K representa un macrociclo de la fórmula (2) done X tiene el significado de un átomo de H o un equivalente de ión metálico de número atómico 20-29, 39, 42, 44 o 57-83, con la condición de que por lo menos dos X representan equivalentes de iones metálicos y que ls grupos carboxi libres que puedan estar presentes puedan estar presentes como sales de bases orgánicas y/o inorgánicas o aminoácidos o amidas de aminoácidos.
ARP040100490A 2003-02-19 2004-02-18 Derivados de benceno sustituidos con trimeros macrociclicos AR043205A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10307759A DE10307759B3 (de) 2003-02-19 2003-02-19 Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel

Publications (1)

Publication Number Publication Date
AR043205A1 true AR043205A1 (es) 2005-07-20

Family

ID=32891780

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100490A AR043205A1 (es) 2003-02-19 2004-02-18 Derivados de benceno sustituidos con trimeros macrociclicos

Country Status (16)

Country Link
EP (1) EP1594851A1 (es)
JP (1) JP2006514664A (es)
KR (1) KR20050105474A (es)
CN (1) CN1753878A (es)
AR (1) AR043205A1 (es)
AU (1) AU2003290032B2 (es)
BR (1) BR0318125A (es)
CA (1) CA2516467A1 (es)
CR (1) CR7937A (es)
DE (1) DE10307759B3 (es)
EC (1) ECSP056026A (es)
MX (1) MXPA05008781A (es)
NO (1) NO20054291L (es)
RU (1) RU2005128834A (es)
WO (1) WO2004074267A1 (es)
ZA (1) ZA200507437B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE102004023093B3 (de) 2004-05-05 2006-03-02 Schering Ag Trimere makrocyclisch substituierte Halogen-Benzolderivate
DE102004026103A1 (de) * 2004-05-25 2005-12-22 Schering Ag Trimere makrocyclisch substituierte Aminoisophthalsäure-Halogen-Benzolderivate
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
JP6124078B2 (ja) * 2010-08-26 2017-05-10 ツイ,クンユァン 巨大環状脂肪族化合物及びその応用
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
CN104721844B (zh) * 2015-02-02 2017-11-03 湖北大学 一种新型ct,mri,稀土荧光三功能微球及其制备方法和应用
CN104672259B (zh) * 2015-02-02 2017-04-05 湖北大学 一种含碘稀土铕(ⅲ)配合物及其制备方法和应用
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN105254529B (zh) * 2015-09-21 2017-05-31 西南石油大学 一种树形席夫碱缓蚀剂的制备方法
JP7034160B2 (ja) 2016-11-28 2022-03-11 バイエル・ファルマ・アクティエンゲゼルシャフト 磁気共鳴画像法に使用するための高緩和度ガドリニウムキレート化合物
CN107445911B (zh) * 2017-06-19 2019-07-05 南京科技职业学院 一种二核含钆磁共振对比剂及其制备与应用
CN113164628A (zh) 2018-11-23 2021-07-23 拜耳股份有限公司 造影介质制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
DE69425572T2 (de) * 1993-06-02 2001-04-26 Bracco Spa Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
FR2736051B3 (fr) * 1995-06-29 1997-09-26 Guerbet Sa Complexes metalliques de polyaminoacides, leur procede de preparation et leur utilisation en imagerie diagnostique
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale

Also Published As

Publication number Publication date
BR0318125A (pt) 2006-02-07
EP1594851A1 (de) 2005-11-16
NO20054291D0 (no) 2005-09-16
DE10307759B3 (de) 2004-11-18
RU2005128834A (ru) 2006-03-20
ZA200507437B (en) 2007-02-28
CR7937A (es) 2006-02-07
CN1753878A (zh) 2006-03-29
NO20054291L (no) 2005-11-17
KR20050105474A (ko) 2005-11-04
JP2006514664A (ja) 2006-05-11
ECSP056026A (es) 2006-01-27
AU2003290032A1 (en) 2004-09-09
AU2003290032B2 (en) 2009-04-23
WO2004074267A1 (de) 2004-09-02
CA2516467A1 (en) 2004-09-02
MXPA05008781A (es) 2006-03-10

Similar Documents

Publication Publication Date Title
AR043205A1 (es) Derivados de benceno sustituidos con trimeros macrociclicos
DK1154991T3 (da) Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer
SE8502573D0 (sv) Fluorescent lanthanide chelates useful as labels of physiologically active materials
AR060636A1 (es) "compuestos nanocristalinos, composicion que comprende a los mismos, uso y metodo de regeneracion de dichos compuestos"
AR028489A1 (es) Concentrados de anticongelantes en base a alquilenglicoles o sus derivados y composiciones de refrigerantes acuosos que los comprenden
CY1112569T1 (el) Παρασιτοκτονος επεξεργασια εδαφων ή υποστρωματων με θειωδεις ενωσεις
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
DE60306817D1 (de) Metallkorrosionsschutz
CY1109295T1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
DE502005009868D1 (de) Metallkomplexe
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
CO5570660A2 (es) Indazolilpirrolotriazinas c-6 modificadas
AR058737A1 (es) Compuestos de benzoazepina con actividad hipotensora hidrosoluble y composicion farmaceutica inyectable que los comprende.
ES2053517T3 (es) Compuesto de elevado peso molecular que comprende una unidad de un compuesto dirigido hacia el aceotir asialoglicoproteinico y una unidad de un compuesto que forma un quelato ligado quimicamente a este y su utilizacion.
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
ATE407176T1 (de) Aromatische triamid-lanthanid-komplexe
ATE516031T1 (de) Verbindungen gegen krebs
CY1112617T1 (el) Φαρμακευτικη συνθεση που περιεχει παραγωγο φαινυλαμιδινης και μεθοδος χρησης της φαρμακευτικης συνθεσης σε συνδυασμο με αντιμυκητιακο μεσο
NO305171B1 (no) N-(Beta-forgrenede alkyl)-1,2-benzisotiazolin-3-oner, samt anvendelse som industrielle biocider
DE602004020984D1 (de) N-phenyl-(4-pyridyl)azinylaminderivate als pflanzenschutzmittel
CY1105813T1 (el) Φαρμακευτικοι συνδυασμοι που βασιζονται σε παραγωγα πυριδοϊνδολονης και σε αντικαρκινικα μεσα
DE60124717D1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
ES2111197T3 (es) 3,4-dioxi-1,2,5-tiadiazoles en parte utiles como fungicidas.
AR050984A1 (es) Derivados de benceno halogenados sustituidos con trimeros macrociclicos
CO5570637A2 (es) Mezclas fungicidas con base en triazolopirimidinas y azol

Legal Events

Date Code Title Description
FB Suspension of granting procedure